[Designer drugs in Jutland].
BACKGROUND
The aim of this investigation was to examine illegal tablets and capsules seized in Jutland, the western part of Denmark, during the period 1995-1999. The drugs are described according to technical appearance (colour, logo, score, diameter) and content of synthetic drugs.


METHODS
All illegal tablets and capsules received during the period 1995-1999 (109 cases containing 192 different samples) were examined.


RESULTS
MDMA was the most common drug and was seen during the entire period. Amphetamine was the second most common drug and has been frequently detected during the the last two years. Drugs like MDE, MBDB, BDB, and 2-CB were rarely seen and they disappeared quickly from the illegal market. MDA appeared on the market at the end of 1999. Only 53% of the tablets contained MDMA as the sole drug. Eighty-one percent of the tablets/capsules contained only one synthetic drug, whereas 13% contained a mixture of two or more synthetic drugs. Six per cent of the samples did not contain a euphoric drug/designer drug. The content of MDMA, MDE, and amphetamine in the tablets varied greatly.


CONCLUSIONS
MDMA is apparently the drug preferred by the users, but still only half of the tablets contained MDMA as the only drug. The rest of the tablets contained either another synthetic drug or a mixture of drugs. In conclusion, the increasing supply of various drugs with different and unpredictable effects and of miscellaneous quality brings about the risk of serious and complicated intoxications.
Simonsen
K W
KW
Aarhus Universitet, Retsmedicinsk Institut, Retskemisk Afdeling. kws@retskemisk.au.dk
Kaa
E
E
D015104:3,4-Methylenedioxyamphetamine / Q000032:analysis / Q000737:chemistry; D000661:Amphetamine / Q000032:analysis / Q000737:chemistry; D002214:Capsules; D003718:Denmark; D015198:Designer Drugs / Q000032:analysis / Q000737:chemistry / Q000600:supply & distribution; D004335:Drug and Narcotic Control; D005554:Forensic Medicine; D006801:Humans; D013048:Specimen Handling; D013607:Tablets
D002214:Capsules; D015198:Designer Drugs; D013607:Tablets; D015104:3,4-Methylenedioxyamphetamine; D000661:Amphetamine